Canada markets closed

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.94000.0000 (0.00%)
At close: 03:55PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 92.08M
Enterprise Value 79.25M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.21
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.10

Trading Information

Stock Price History

Beta (5Y Monthly) 1.67
52-Week Change 316.17%
S&P500 52-Week Change 3-13.03%
52 Week High 33.3300
52 Week Low 31.5200
50-Day Moving Average 32.0534
200-Day Moving Average 32.3634

Share Statistics

Avg Vol (3 month) 344.76k
Avg Vol (10 day) 352.5k
Shares Outstanding 546.27M
Implied Shares Outstanding 6N/A
Float 842.48M
% Held by Insiders 19.53%
% Held by Institutions 10.07%
Shares Short (Jun 14, 2022) 425.97k
Short Ratio (Jun 14, 2022) 40.82
Short % of Float (Jun 14, 2022) 4N/A
Short % of Shares Outstanding (Jun 14, 2022) 40.06%
Shares Short (prior month May 12, 2022) 420.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-96.43%
Return on Equity (ttm)-172.34%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.54M
Net Income Avi to Common (ttm)-15.45M
Diluted EPS (ttm)-0.3680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.83M
Total Cash Per Share (mrq)0.27
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.99
Book Value Per Share (mrq)0.28

Cash Flow Statement

Operating Cash Flow (ttm)-11.21M
Levered Free Cash Flow (ttm)-5.49M